Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL7... ( Robust Pathway Inhibition in Tumor a...)

Exelixis Reports Positive Clinical Pharmacodynamics Data for PI3K/mTOR Inhibitor XL765 at ASCO

Date:5/31/2008

Robust Pathway Inhibition in Tumor and Surrogate Tissues at Well-Tolerated

Doses

CHICAGO, May 31 /PRNewswire-FirstCall/ -- Exelixis, Inc. (Nasdaq: EXEL) reported interim data from a phase 1 dose-escalation trial of XL765, a novel small molecule inhibitor of phosphoinositide-3 kinase (PI3K) and mTOR, which are implicated in tumor cell proliferation, survival, and resistance to chemotherapy and radiotherapy. The trial is being carried out in patients with metastatic or unresectable solid tumors for which known effective measures do not exist or are no longer effective. Kyriakos Papadopoulos, MD, Clinical Investigator at South Texas Accelerated Research Therapeutics (START) and a lead investigator in the trial, presented the data in the PI-3 Kinase/mTOR Directed Agents oral abstract session (Abstract #3510) at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO).

There were 19 patients available for safety, pharmacokinetic, and tumor response analyses as of the May 1, 2008 cutoff. Results from pharmacodynamics analyses indicate that XL765 inhibits the PI3K/mTOR pathway in patients at well-tolerated doses. Reductions of 80-90% in the phosphorylation of pathway components including AKT, 4EBP1, and S6, and a reduction of 54% in cell proliferation (as assessed by Ki67 staining) were observed in tumor tissue from a patient with chondrosarcoma at the 60 mg twice-a-day (BID) dose level. Reductions in the phosphorylation of these pathway components were also observed at this dose level in surrogate patient tissues, including hair bulbs, skin, and peripheral blood cells. The pattern of inhibition of protein phosphorylation observed in these tissues is consistent with observations
'/>"/>

SOURCE Exelixis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5
Related medicine technology :

1. GlaxoSmithKline Accelerates Review of Exelixis XL880
2. Exelixis Announces September 5 Webcast of Its 2007 IASLC Investor and Analyst Briefing
3. Exelixis Reports Top-Line Results of the Phase 2 Trial of XL784 in Patients With Proteinuria Associated With Diabetic Nephropathy
4. Updated Phase 1 Data for Exelixis XL184 Demonstrate Pharmacodynamic and Clinical Anti-Tumor Activity
5. Exelixis Reports XL647 Clinical Data at AACR-NCI-EORTC Conference
6. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
7. Phase 2 Trial Results for Exelixis XL784 Presented at the 2007 American Society of Nephrology Conference
8. Exelixis Presents Encouraging Phase 1 Data For XL019, A Novel Selective Inhibitor of JAK2
9. Exelixis Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lung Cancer
10. Exelixis Announces First Quarter 2008 Financial Results
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound

Post Your Comments:

(Date:5/24/2013)... Sinovac Biotech Ltd. (NASDAQ: SVA ... China , announced that Sinovac ... obtained the Certificate of Good Manufacturing Practices for ... and Food Administration (CFDA) for its proprietary vaccines, ... Changping filing and packaging facility. The GMP certificate ...

(Date:5/23/2013)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ) ... Life Science Firm of the Year by the Tech Council ... at the TCM,s 25 th Annual Tech Awards Celebration ... Awards Celebration recognizes the leaders and innovators in the technology ... and the surrounding regions. "We are deeply ...

(Date:5/23/2013)... , May 23, 2013 Haemonetics Corporation (NYSE: ... , CFO & EVP-Business Development, will present at The Deutsche ... Boston, MA on May 29, 2013 ... ) The public may access Mr. Lindop,s ... About Haemonetics Haemonetics (NYSE: HAE ...

Breaking Medicine Technology:Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2 Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3 Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2

[0] Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines [0] Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland [0] Haemonetics to Present at The Deutsche Bank 38th Annual dbAccess Health Care Conference

... CHICAGO, Jan. 19, 2012 According to Marcia Crosse (Director, ... its mission to protect American health has been compromised. In ... on GAO,s High-Risk List, she says : ... in protecting the health of all Americans. FDA,s role is ...

... 2012 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... of 9,500,000 shares of its common stock at a ... gross proceeds to Neurocrine from this offering, before deducting ... by Neurocrine, are expected to be approximately $77 million. ...

Cached Medicine Technology:Physician-Patient Alliance for Health & Safety: Can There Be Too Much FDA Oversight? 2 Physician-Patient Alliance for Health & Safety: Can There Be Too Much FDA Oversight? 3 Physician-Patient Alliance for Health & Safety: Can There Be Too Much FDA Oversight? 4 Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock 2 Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock 3

Physician-Patient Alliance for Health & Safety: Can There Be Too Much FDA Oversight?Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock

(Date:5/25/2013)... (HealthDay News) -- Many viruses and parasites that affect ... -- a bacteria-borne illness than can result in liver ... parks, according to a veterinarian. These germs ... the air, said Dr. Susan Nelson, a clinical associate ... of these serious diseases can be fatal, even with ...

(Date:5/25/2013)... 2013 Providing patients with their best weight ... of weight management professionals. But, aside from educating patients on ... Doc’s hCG diets also provide patients, who have ... like bullying, more control over their lives by achieving their ... the underlying factors of weight gain derived from earlier abuse, ...

(Date:5/25/2013)... New York,NY (PRWEB) May 25, 2013 ... SizeItUp officially declared the integration of the 2012 ... Lamborghini Aventador is the latest entrant in the list ... Designed intelligently, the vehicle is all set to thrill ... with vicious acceleration power and spectacular looks, the 2012 ...

(Date:5/25/2013)... Vancouver, BC (PRWEB) May 25, 2013 ... of the most beautiful and powerful women that ever ... was felt by some of the most powerful men ... used many beauty remedies to keep her skin glowing ... treatments made with bees- wax, maringa oil and cyprus ...

(Date:5/25/2013)... 25, 2013 For college students, ... week. Increasingly, they are turning to prescription stimulants ... study. For more on this, go to ... facility, warns that students who pick up Adderall, ... risk for developing a physical and psychological dependency. ...

Breaking Medicine News(10 mins):Health News:Hidden Dangers Dog Dog Parks 2 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2 Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3 Health News:Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2 Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3 Health News:Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals 2

[0] Hidden Dangers Dog Dog Parks [0] hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain [0] Rim Fitments Provider SizeItUp Launches The Database Integration For The 2012 Lamborghini Aventador [0] The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician [0] Addiction and Drug Abuse: Study Drug Adderall Abuse Spikes During Finals

... America and Merrill Lynch 2009 Health Care Conference on May ... May 19 -SAN DIEGO, May 6 Gen-Probe Incorporated (Nasdaq: ... present at the Bank of America and Merrill Lynch 2009 ... at approximately 9:20 a.m. Eastern time, and at the Deutsche ...

... Infotrieve, Inc. ( www.infotrieve.com ), the ... revolutionary software solution Content SCM(R) ... Science or Technology Service category of the 2009 CODiE ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20080709/LAW008LOGO ...

... the 125,000-member Indiana American Legion today challenged the Indiana ... act plainly on behalf of the youngsters at the ... called on legislators to "not use the current budget ... plans announced by the Indiana State Department of Health, ...

... HOUSTON, May 6 Carriage Services, Inc. (NYSE: CSV ) today announced results for the first quarter ended March 31, 2009. ... Selected Financial Results , (amounts in millions, except per share amounts) , , ... Q1 Q1, ... 2009 Change, ...

... For Using A Knowledgeable Travel Advisor As The Swine ... The sudden outbreak of the H1N1 virus, more ... by surprise, causing opinions to become unsubstantiated rumors over ... luxury travel network, Virtuoso, has reached out to its ...

... First Quarter Highlights:- Revenue gained 7.5% to $187 ... 58.7% compared to Q1 2008, rising to $5.9 ... in client census and rate combined with increased ... from operations totaled $7.8 million- Sale of NET ...

Gen-Probe to Webcast Two Upcoming Investor Presentations Infotrieve's Content SCM(R) Wins 2009 CODiE Award Legion Demands 'Courage' From Legislators in Battle Over Children's Home Carriage Services Announces First Quarter 2009 Results Virtuoso(R) Affirms Travel Amidst H1N1 Flu Scare Providence Service Corporation Announces Record Revenues and Earnings in the First Quarter of 2009

High temperature loop tip cautery....

High temp cauteries, fine tip micro....

Thru cut kerrison style punch 30 deg, 2.75 X 1.4 mm cut, 110 working length....

6 mm, 45 degree upwards, detachable....

Medicine Products:

High Temperature Cauteries High Temp Cauteries Kerrison style punch Ferris-Smith Kerrison punches